Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Status: Archived
mi
from
Austin, TX
Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Status: Archived
Updated: 1/1/1970
Eye Institute of Austin
mi
from
Austin, TX
A Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
A Randomized, Prospective, Multi-center, Patient-masked, Bilateral Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
Status: Archived
mi
from
Fort Worth, TX
A Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
A Randomized, Prospective, Multi-center, Patient-masked, Bilateral Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Status: Archived
mi
from
Bethesda, MD
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
Study to Assess the Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
mi
from
Rochester, NY
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
Study to Assess the Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
Updated: 1/1/1970
Bausch & Lomb
mi
from
Rochester, NY
Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
A Two Arm Prospective, Randomized, Double-Masked Clinical Evaluation of Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
Status: Archived
mi
from
Aliso Viejo, CA
Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
A Two Arm Prospective, Randomized, Double-Masked Clinical Evaluation of Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
Status: Archived
Updated: 1/1/1970
Bausch & Lomb
mi
from
Aliso Viejo, CA
The Effects of a Single Intravenous Administration of AIN457 or ACZ885 in Dry Eye Patients
A Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study of Intravenous ACZ885 or AIN457 in Dry Eye Syndrome
Status: Archived
mi
from
Andover, MA
The Effects of a Single Intravenous Administration of AIN457 or ACZ885 in Dry Eye Patients
A Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study of Intravenous ACZ885 or AIN457 in Dry Eye Syndrome
Status: Archived
Updated: 1/1/1970
ORA Inc
mi
from
Andover, MA
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
mi
from
Iowa City, IA
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
mi
from
Boston, MA
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
mi
from
Fort Worth, TX
Alcon Call Center
mi
from
Fort Worth, TX
IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Intraocular Pressure Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Status: Archived
mi
from
Omaha, NE
IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Intraocular Pressure Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Status: Archived
Updated: 1/1/1970
University of Nebrasaka Medical Center
mi
from
Omaha, NE
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease
Status: Archived
mi
from
Andover, MA
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease
Status: Archived
Updated: 1/1/1970
ORA Inc
mi
from
Andover, MA
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Phoenix, AZ
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Beverly Hills, CA
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Fort Myers, FL
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Winter Haven, FL
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Boston, MA
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Charlotte, NC
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Dallas, TX
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Texas Retina Associates
mi
from
Dallas, TX
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
mi
from
Houston, TX
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Retina Consultants of Houston
mi
from
Houston, TX
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 2, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 and 5% MIM-D3 Ophthalmic Solutions in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model
Status: Archived
mi
from
Andover, MA
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 2, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 and 5% MIM-D3 Ophthalmic Solutions in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model
Status: Archived
Updated: 1/1/1970
ORA Inc
mi
from
Andover, MA
Tissue Studies of Human Eye Diseases
Immunopathology and Molecular Pathology of Ocular Diseases in Humans
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Tissue Studies of Human Eye Diseases
Immunopathology and Molecular Pathology of Ocular Diseases in Humans
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Natural History and Genetic Studies of Usher Syndrome
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Natural History and Genetic Studies of Usher Syndrome
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated: 12/31/1969
Queens College of the City University of New York
mi
from
New York, NY
Click here to add this to my saved trials
Natural History and Genetic Studies of Usher Syndrome
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Natural History and Genetic Studies of Usher Syndrome
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Durham, NC
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Salt Lake City, UT
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Guangzhou,
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Eye Research Institute, Zhongstan Ophthalmic Ctr, Sun Yat-Sen University
mi
from
Guangzhou,
Click here to add this to my saved trials
Clinical and Genetic Studies in Families With Myopia and Related Diseases
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Clinical and Genetic Studies in Families With Myopia and Related Diseases
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clinical and Genetic Studies in Families With Myopia and Related Diseases
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Guangzho,
Clinical and Genetic Studies in Families With Myopia and Related Diseases
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Zhongshan Ophthalmic Center, Sun Yat-sen University
mi
from
Guangzho,
Click here to add this to my saved trials
Novel Diagnostics for Ocular Structure
Optical Coherence Tomography Domain Reflectometry & Optical Coherence Tomography Measurements of Intraocular Structure
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Novel Diagnostics for Ocular Structure
Optical Coherence Tomography Domain Reflectometry & Optical Coherence Tomography Measurements of Intraocular Structure
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated: 12/31/1969
Aston Ambulatory Care Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases
Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases
Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Los Angeles, CA
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Jules Stein Eye Institute, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Cleveland, OH
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Guangzhou,
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Zhongshan Opthalmic Center
mi
from
Guangzhou,
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Davis, CA
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
La Jolla, CA
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Los Angeles, CA
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
University of Southern California/Doheny Eye Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Oakland, CA
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Children's Hospital and Research Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Pomona, CA
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Western University of Health Sciences
mi
from
Pomona, CA
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
San Francisco, CA
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
West Coast Retina Medical Group
mi
from
San Francisco, CA
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Stanford, CA
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Stanford California Vitreo-Retinal Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  12/31/1969
mi
from
Tampa, FL
Repository for Inherited Eye Diseases
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Associates
mi
from
Tampa, FL
Click here to add this to my saved trials